0001179110-14-001911.txt : 20140204
0001179110-14-001911.hdr.sgml : 20140204
20140204191225
ACCESSION NUMBER: 0001179110-14-001911
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140203
FILED AS OF DATE: 20140204
DATE AS OF CHANGE: 20140204
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KYTHERA BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001436304
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 27200 WEST AGOURA ROAD
STREET 2: SUITE 200
CITY: CALABASAS
STATE: CA
ZIP: 91301
BUSINESS PHONE: 818-587-4500
MAIL ADDRESS:
STREET 1: 27200 WEST AGOURA ROAD
STREET 2: SUITE 200
CITY: CALABASAS
STATE: CA
ZIP: 91301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Webster Jeffrey D
CENTRAL INDEX KEY: 0001559582
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35663
FILM NUMBER: 14574006
MAIL ADDRESS:
STREET 1: C/O KYTHERA BIOPHARMACEUTICALS, INC.
STREET 2: 27200 WEST AGOURA ROAD, SUITE 200
CITY: CALABASAS
STATE: CA
ZIP: 91301
4
1
edgar.xml
FORM 4 -
X0306
4
2014-02-03
0
0001436304
KYTHERA BIOPHARMACEUTICALS INC
KYTH
0001559582
Webster Jeffrey D
C/O KYTHERA BIOPHARMACEUTICALS, INC.
27200 WEST AGOURA ROAD, SUITE 200
CALABASAS
CA
91301
0
1
0
0
Senior VP, Operations
Common Stock
2014-02-03
4
M
0
4000
0.76
A
4000
D
Common Stock
2014-02-03
4
S
0
2200
44.9993
D
1800
D
Common Stock
2014-02-03
4
S
0
1800
45.8998
D
0
D
Stock Option (right to buy)
0.76
2014-02-03
4
M
0
4000
0
D
2017-03-13
Common Stock
4000
50761
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan which expires April 30, 2014.
100% of the shares subject to the option are fully vested and exercisable.
The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $44.57 to $45.50, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $45.515 to $46.33, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
/s/ Keith Klein, as Attorney-in-Fact for Jeffrey D. Webster
2014-02-04